HIF1A and neoplasm: CCL28 upregulation is under the control of HIF-1α [75], and the alleviation of hypoxia by TVN will reduce HIF-1α, abrogating CCL28 tumor-promoting effects, which leads to the inhibition of tumor growth [64,75].